These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31529560)
1. Immunogenicity of recombinant outer membrane porin protein and protective efficacy against lethal challenge with Bordetella bronchiseptica in rabbits. Zhang H; Zhang H; Xiong B; Fan G; Cao Z J Appl Microbiol; 2019 Dec; 127(6):1646-1655. PubMed ID: 31529560 [TBL] [Abstract][Full Text] [Related]
2. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen. Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369 [No Abstract] [Full Text] [Related]
4. Greater efficacy of the ECMS-oil adjuvant over other formulations on immune responses against Bordetella bronchiseptica in rabbits and the underlying mechanism. Xiao C; Bao G; Liu Y; Wei Q; Ji Q; Liu Y; Pan L Int Immunopharmacol; 2016 Sep; 38():194-203. PubMed ID: 27288753 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Rg1-Oil Adjuvant on Inducing Immune Responses against Chenwen X; Quanan J; Yee H; Yan L; Jiaoyu W; Qiang W; Litao Q; Li N; Guolian B J Immunol Res; 2021; 2021():8835919. PubMed ID: 33575363 [No Abstract] [Full Text] [Related]
6. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin. Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750 [TBL] [Abstract][Full Text] [Related]
7. aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge. Zhang Q; Hu R; Hu J; He H; Tang X; Jin M; Chen H; Wu B Res Vet Sci; 2013 Feb; 94(1):55-61. PubMed ID: 22892249 [TBL] [Abstract][Full Text] [Related]
8. Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica. Sukumar N; Love CF; Conover MS; Kock ND; Dubey P; Deora R Infect Immun; 2009 Feb; 77(2):885-95. PubMed ID: 19064638 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchiseptica. Zhao Z; Xue Y; Tang X; Wu B; Cheng X; He Q; Zhang C; Guo A; Jin M; Chen H Vaccine; 2009 Apr; 27(18):2523-8. PubMed ID: 18852008 [TBL] [Abstract][Full Text] [Related]
10. [Protecting mice from fatal Bordetella bronchiseptica infection by immunization with recombinant pertactin antigens]. Zhao Z; Xue Y; Wu B; Duan L; Chen H; Tang X; Hu R; He H; Li Z Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):337-41. PubMed ID: 18479060 [TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity and protective efficacy of pertactin recombinants against Bordetella bronchiseptica challenge]. Zhao Z; Wang C; Xue Y; Ding K; Zhang C; Cheng X; Li Y; Liu Y; Wu T Wei Sheng Wu Xue Bao; 2010 Sep; 50(9):1239-45. PubMed ID: 21090265 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Immunization of Dogs With Muhammad A; Kassmannhuber J; Rauscher M; Falcon AA; Wheeler DW; Zhang AA; Lubitz P; Lubitz W Front Immunol; 2019; 10():1377. PubMed ID: 31293571 [TBL] [Abstract][Full Text] [Related]
13. Cross protection studies on Bordetella bronchiseptica in mice using an intracerebral challenge model. Lendvai N; Magyar T; Semjén G Vet Microbiol; 1992 Jun; 31(2-3):191-6. PubMed ID: 1626369 [TBL] [Abstract][Full Text] [Related]
14. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562 [TBL] [Abstract][Full Text] [Related]
15. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407 [TBL] [Abstract][Full Text] [Related]
16. Protective effect by cell-free antigen obtained from culture supernatant of phase I Bordetella bronchiseptica. Ohgitani T; Uchida C; Okabe T; Sasaki N J Vet Med Sci; 1992 Feb; 54(1):37-42. PubMed ID: 1532748 [TBL] [Abstract][Full Text] [Related]
17. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Mann P; Goebel E; Barbarich J; Pilione M; Kennett M; Harvill E Infect Immun; 2007 Jul; 75(7):3665-72. PubMed ID: 17452472 [TBL] [Abstract][Full Text] [Related]
18. Strain- and growth condition-dependent variability in outer membrane protein expression by Bordetella bronchiseptica isolates from dogs. Keil DJ; Fenwick B Am J Vet Res; 1999 Aug; 60(8):1016-21. PubMed ID: 10451215 [TBL] [Abstract][Full Text] [Related]
19. Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Montaraz JA; Novotny P; Ivanyi J Infect Immun; 1985 Mar; 47(3):744-51. PubMed ID: 3972452 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs. Ellis JA; Krakowka GS; Dayton AD; Konoby C J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]